Please login to view this media
- Talk
- 21/05/2025
- UK
One-Stage Versus Two-Stage Revision Hip Arthroplasty - Can We Confirm the Data from Metaanalysis in Real World - Made with Clipchamp
Description
The final speaker of the conference is Professor Carsten Perka, who is the Surgeon In-Chief at The Center for Musculoskeletal Surgery in Berlin. He has contributed significantly to the field of periprosthetic joint infection (PJI) with over 700 publications. Professor Perka has held several leadership roles in orthopedic societies and is expected to discuss the outcomes of single-stage versus two-stage revision surgery using real-world data from Germany, highlighting the concerning increase in revisions due to infection.
During his presentation, he examines the current revision rates in Germany, noting that nearly 30% of all revisions are infection-related, with a notable percentage attributed to septic reasons. He compares findings from literature on revision techniques, revealing a slightly improved reinfection rate for single-stage revisions as compared to two-stage revisions. However, when analyzing the data from a national registry, he finds that the actual rates of readmission post-surgery are alarmingly higher, with a 30% rate for septic revisions, contradicting previous literature claims.
Perka emphasizes the importance of robust registry data, as it reflects real-world outcomes rather than selective cohorts typically seen in studies. He warns against making premature recommendations for one-stage revisions across the board, underscoring that the lack of rigorous criteria in real-world data may lead to higher-than-expected complication rates. His findings also highlight a concerning trend regarding mortality rates, particularly for patients undergoing one-stage revisions, raising questions about the long-term success of these surgeries. He concludes that more extensive data collection and careful consideration of the factors surrounding individual patient cases are needed to optimize surgical outcomes, ultimately advocating for a tailored approach to treatment based on comprehensive data analysis.